Christopher Samler

Bio

In 1997, was appointed Weston Medical Group's first CEO and led it from concept through several rounds of funding to a full UK listing in 2000. Prior to this, was the first CEO of Imutran, a Cambridge-based healthcare company that was sold to the Swiss based pharmaceutical multinational, Novartis. Worked for the Boston Consulting Group in London prior to joining Baxter International in 1988 where he held a succession of strategy, sales and marketing and general management positions. MA from the University of Oxford. MBA from the Harvard Business School.